Enliven Therapeutics
ELVN
#5576
Rank
$0.88 B
Marketcap
$18.10
Share price
1.29%
Change (1 day)
-1.09%
Change (1 year)

Revenue for Enliven Therapeutics (ELVN)

Revenue in 2024 (TTM): N/A

a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enliven Therapeutics from 2022 to 2024

Annual revenue

Year Revenue Change
2024 N/A
2023 N/A
2022 N/A